MedTrace Logo

Using Smart Phone Technology in Detecting the Presence of Atrial Fibrillation

NCT02214069 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2017-12-13

No results posted yet for this study

Summary

The purpose of this study is to examine whether patients can use the AliveCor case to record their heart rhythm and to assess the accuracy of the software in detecting AF vs sinus rhythm

Conditions

Interventions

DEVICE

Record and transmit heart rhythm

The patient uses the AliveCor device to record and transmit heart rhythm two times a day. The patient, device software, and Electrophysiologist interpret the rhythm

Sponsors & Collaborators

  • AliveCor

    collaborator INDUSTRY

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Khaldoun Tarakji, MD · The Cleveland Clinic

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2016-10-31
Completion
2017-07-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02214069 on ClinicalTrials.gov